We are live on ! Find out more
PAVMZ

PAVmed Inc. Series Z Warrant
PAVMZ

Delisted

PAVMZ was delisted on the 30th of April, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in PAVmed Inc. Series Z Warrant in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $1.09K → $0 (-$1.09K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
–
Holders Change
-4
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$837
2
Citadel Advisors
Citadel Advisors
Florida
-$234
3
UBS Group
UBS Group
Switzerland
-$20
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
– -$837 -149,408 Closed
Citadel Advisors
2
Citadel Advisors
Florida
– -$234 -41,721 Closed
UBS Group
3
UBS Group
Switzerland
– -$20 -3,205 Closed

PAVMZ Hedge Fund Activity: Q2 2025 in Review

0 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q2 2025, worth a combined $0 — down 100% from $1.09K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of PAVMZ and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Susquehanna International Group, exiting entirely with an estimated $837 sold.

  • 0 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q2 2025, down from 4 in Q1 2025.
  • Funds reported $0 of PAVmed Inc. Series Z Warrant stock for Q2 2025, down 100% quarter-over-quarter.
  • 0 funds opened new PAVmed Inc. Series Z Warrant positions in Q2 2025 and 4 closed out, a net change of -4 holders.
  • The largest PAVmed Inc. Series Z Warrant seller in Q2 2025 was Susquehanna International Group, an estimated $837 sold.

Based on aggregated 13F filings for Q2 2025.